ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

ANI Pharmaceuticals (Nasdaq: ANIP) announced that CEO Nikhil Lalwani will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 3:45 p.m. ET.

Rhea-AI Summary

ANI Pharmaceuticals (Nasdaq: ANIP) announced that CEO Nikhil Lalwani will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 3:45 p.m. ET. A live and archived webcast will be available on the company’s investor relations website for 90 days.

Argus May 27 session

+0.43% close to close Open Argus

Details

News Market Reaction – ANIP

In the May 27 session, ANIP gained 0.43%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights ANIP’s continued engagement with institutional investors via the Jeffer...

Analysis

This announcement highlights ANIP’s continued engagement with institutional investors via the Jefferies Global Healthcare Conference on June 3, 2026, including a 3:45 p.m. ET fireside chat and 90-day webcast replay. It follows recent FDA approvals, product launches, and raised 2026 guidance, which together outline a growth-focused story. Investors may watch for any qualitative commentary or strategic updates from management, while keeping recent insider activity and prior mixed price reactions to positive news in view.

Key Figures

Conference date: June 3, 2026 Conference time: 3:45 p.m. ET Webcast replay period: 90 days

Conference date

June 3, 2026

Jefferies Global Healthcare Conference fireside chat

Conference time

3:45 p.m. ET

Scheduled start time of fireside chat webcast

Webcast replay period

90 days

Duration the conference webcast replay will be accessible

Historical Context

5 past events · Latest: May 08

5 events

1. May 08

   Earnings beat, guidance

   24h Move

   -2.4%

   Strong Q1 2026 growth, higher 2026 guidance, $100M buyback authorization.

2. Apr 24

   Earnings call notice

   24h Move

   +0.7%

   Scheduled May 8 earnings release and webcast details for Q1 2026.

3. Apr 20

   FDA approval, launch

   24h Move

   +1.0%

   FDA approval and launch of Pimozide Tablets with 180-day CGT exclusivity.

4. Apr 13

   Generic launch

   24h Move

   -0.1%

   Launch of Carbamazepine ER capsules in limited-competition generic market.

5. Apr 08

   FDA approval, launch

   24h Move

   -0.6%

   FDA final approval and launch of Isosorbide Mononitrate generic Monoket.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PRINCETON, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference as follows:

Date:	Wednesday, June 3, 2026
Time:	3:45 p.m. ET
Webcast:	Click Here

The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.

About ANI

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit https://www.anipharmaceuticals.com.

Investor Relations:
Irina Koffler, Vice President, Investor Relations
T: 917-734-7387
E: Irina.koffler@anipharmaceuticals.com

Media Relations:
Argot Partners
T: 212-600-1494
E: ani@argotpartners.com

SOURCE: ANI Pharmaceuticals, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will ANI Pharmaceuticals (ANIP) present at the 2026 Jefferies Global Healthcare Conference?

ANI Pharmaceuticals will present on Wednesday, June 3, 2026, at 3:45 p.m. ET. According to ANI Pharmaceuticals, CEO Nikhil Lalwani will join a fireside chat as part of the 2026 Jefferies Global Healthcare Conference program.

Who is representing ANI Pharmaceuticals (ANIP) at the 2026 Jefferies Global Healthcare Conference?

ANI Pharmaceuticals will be represented by CEO Nikhil Lalwani in a fireside chat session. According to ANI Pharmaceuticals, his appearance is scheduled for June 3, 2026, at 3:45 p.m. ET during the Jefferies Global Healthcare Conference.

How can investors access the ANI Pharmaceuticals (ANIP) webcast from the 2026 Jefferies Global Healthcare Conference?

Investors can access the live and archived webcast via the ANI Pharmaceuticals website. According to ANI Pharmaceuticals, the link will be under the Investors section, within Events and Presentations, for convenient online streaming.

How long will the ANI Pharmaceuticals (ANIP) Jefferies 2026 conference replay be available?

The replay of ANI Pharmaceuticals’ Jefferies 2026 conference fireside chat will be available for 90 days. According to ANI Pharmaceuticals, both live and archived webcasts will be hosted on the company’s investor relations Events and Presentations page.

Where on ANI Pharmaceuticals’ (ANIP) website will the 2026 Jefferies conference webcast be posted?

The webcast will be posted in the Investors section under Events and Presentations on ANI’s website. According to ANI Pharmaceuticals, both the live stream and 90-day replay will be accessed from this dedicated investor page.